Long-term Care Issues — MCQs
Which of the following is a cognitive disorder?
Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?
Movement across socioeconomic levels is termed as:
All are true about dying declaration except
Dementia of Alzheimer's type is not associated with one of the following
Which of the following is a set point for plans but is something that cannot be quantified or measured?
Rivastigmine & donepezil are drugs used predominantly in the management of ?
Regarding Alzheimer's disease which is/are not true :
Which of the following antidepressants can be safely used in elderly depression?
"Sundowning" is seen in which of the following conditions?
Long-term Care Issues Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following is a cognitive disorder?
- A. Dementia (Correct Answer)
- B. Intellectualization
- C. Depersonalization
- D. All of the options
Explanation: ***Dementia*** - **Dementia** is a syndrome characterized by a significant decline in **cognitive function**, specifically in areas like memory, language, problem-solving, and reasoning. - It impairs a person's ability to perform everyday activities and is caused by various diseases that damage brain cells, such as **Alzheimer's disease**. *Intellectualization* - **Intellectualization** is an **ego defense mechanism** where a person uses excessive abstract thinking and intellectual concepts to avoid confronting emotions or internal conflicts. - While it involves thought processes, it is a psychological coping mechanism, not a cognitive disorder characterized by neurological impairment. *Depersonalization* - **Depersonalization** is a dissociative symptom characterized by a feeling of detachment from one's own body, thoughts, feelings, or actions, as if observing oneself from outside. - It's a symptom of a **dissociative disorder** or other mental health conditions, not a disorder primarily defined by cognitive impairment in the way dementia is. *All of the options* - This option is incorrect because only dementia is classified as a primary **cognitive disorder**. - Intellectualization and depersonalization are psychological phenomena or symptoms of other mental health conditions, not standalone cognitive disorders.
Question 2: Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?
- A. Tolterodine (Correct Answer)
- B. Mirabegron
- C. Behavioral therapy/bladder training
- D. Oxybutynin
- E. Trospium
Explanation: ***Tolterodine*** - **Tolterodine** is a **muscarinic antagonist** that blocks acetylcholine receptors in the bladder, reducing detrusor muscle contractions and overactive bladder symptoms. - Unlike some other anticholinergics like oxybutynin, it has a **lower propensity to cross the blood-brain barrier** and thus a reduced risk of exacerbating cognitive impairment in patients with dementia. *Mirabegron* - **Mirabegron** is a **beta-3 adrenergic agonist** that relaxes the detrusor muscle, increasing bladder capacity. - While it has a different mechanism of action and is less likely to cause anticholinergic cognitive side effects than older anticholinergics, it can still cause **hypertension** and **tachycardia**, which may be problematic in elderly patients with comorbidities. *Behavioral therapy/bladder training* - **Behavioral therapy** and **bladder training** are important first-line treatments for overactive bladder. - However, for patients with **dementia**, cognitive impairment often makes adherence to and understanding of these complex therapies challenging or impossible without significant caregiver support. *Oxybutynin* - **Oxybutynin** is an **anticholinergic drug** that is effective for overactive bladder. - However, it has a **high affinity for muscarinic receptors** in the brain and readily crosses the blood-brain barrier, significantly increasing the risk of **cognitive impairment, confusion, and delirium** in elderly patients, especially those with pre-existing dementia. *Trospium* - **Trospium** is a **quaternary amine anticholinergic** that is hydrophilic and has minimal blood-brain barrier penetration. - While theoretically safer than oxybutynin in terms of CNS effects, it has **lower bladder selectivity** compared to tolterodine and may cause more peripheral anticholinergic side effects (dry mouth, constipation).
Question 3: Movement across socioeconomic levels is termed as:
- A. Social equality
- B. Social upliftment
- C. Social mobility (Correct Answer)
- D. Social insurance
Explanation: ***Social mobility*** - This term refers to the **movement of individuals or groups** between different socioeconomic positions. - It describes changes in **social status**, whether upward, downward, or horizontal, within a societal hierarchy. *Social equality* - This concept refers to a state where all individuals within a society have the **same rights, opportunities, and social status**, regardless of background. - It specifically addresses fairness and justice in access to resources and treatment, rather than movement between social tiers. *Social upliftment* - This term generally refers to efforts or programs aimed at **improving the social and economic conditions** of disadvantaged groups or communities. - While it can lead to upward social mobility, it specifically describes the *process of improvement* rather than the general concept of movement between levels. *Social insurance* - This refers to a system where contributions are made by individuals and employers to provide **financial protection** against various risks like unemployment, sickness, or old age. - It is a specific type of social welfare program and does not describe the movement between socioeconomic levels.
Question 4: All are true about dying declaration except
- A. Cross examination permitted (Correct Answer)
- B. Practiced in India
- C. Oath is not needed
- D. Made to Judicial Magistrate Or Medical officer
Explanation: ***Cross-examination permitted*** - A **dying declaration** is an exception to the hearsay rule, and the declarant (the dying person) is **not available for cross-examination**, as they are deceased. - The principle is based on the belief that a dying person would not lie, thus making cross-examination unnecessary for truthfulness in this context. *Practiced in India* - Dying declarations are indeed a recognized and practiced form of evidence in **Indian law**, specifically under Section 32(1) of the Indian Evidence Act, 1872. - They are considered a significant piece of evidence in criminal proceedings, especially in cases of murder or culpable homicide. *Oath is not needed* - A dying declaration does **not require an oath** to be administered to the declarant at the time of making the statement. - The belief that a person on the verge of death would speak the truth, known as the maxim **"nemo moriturus praesumitur mentiri"** (no one about to die is presumed to lie), substitutes the need for an oath. *Made to Judicial Magistrate Or Medical officer* - While a dying declaration can be made to **anyone**, including ordinary citizens, statements recorded by a **Judicial Magistrate** or a **Medical Officer** are generally given higher evidentiary value due to their impartiality and official capacity. - A medical officer can attest to the declarant's **mental fitness** at the time of making the statement, which is crucial for its admissibility.
Question 5: Dementia of Alzheimer's type is not associated with one of the following
- A. Delusions
- B. Apraxia and aphasia
- C. Cerebral infarcts (Correct Answer)
- D. Depressive symptoms
Explanation: ***Cerebral infarcts*** - **Cerebral infarcts** are characteristic of **vascular dementia**, where brain damage is caused by reduced blood flow due to stroke or transient ischemic attacks. - While an individual with Alzheimer's could coincidentally have a stroke, **cerebral infarcts** are not a primary neuropathological feature or an expected clinical association inherent to the progression of Alzheimer's disease itself. *Delusions* - **Delusions**, particularly paranoid delusions (e.g., believing caregivers are stealing from them), are relatively common **psychotic symptoms** that can occur in later stages of Alzheimer's disease. - They are considered a behavioral and psychological symptom of dementia (BPSD) and can significantly impact the patient's and caregiver's quality of life. *Apraxia and aphasia* - **Apraxia** (difficulty with motor tasks despite intact motor function) and **aphasia** (language difficulties) are core **cognitive symptoms** that define Alzheimer's dementia. - These are progressive deficits in executive function, language, and motor skills that lead to functional impairment. *Depressive symptoms* - **Depressive symptoms**, including apathy, anhedonia, and low mood, are highly prevalent in individuals with Alzheimer's disease, particularly in the earlier stages. - They can be a reaction to the cognitive decline and loss of independence, or a direct result of the neurodegenerative process affecting mood-regulating brain regions.
Question 6: Which of the following is a set point for plans but is something that cannot be quantified or measured?
- A. Target
- B. Objective
- C. Mission (Correct Answer)
- D. Goal
Explanation: ***Mission*** - A **mission statement** defines an organization's fundamental purpose and values, guiding its actions and decisions. - It describes **why an organization exists** and what it aims to achieve, but it is typically a broad, qualitative statement that cannot be directly measured. *Target* - A **target** is a specific, measurable result that an organization aims to achieve within a defined timeframe. - Targets are quantifiable and used to track progress toward objectives and goals. *Objective* - An **objective** is a specific aim or desired outcome that an individual or organization plans to achieve. - Objectives are typically quantifiable, time-bound, and measurable, providing clear criteria for success. *Goal* - A **goal** is a desired result or outcome that a person or system envisions, plans, and commits to achieve. - While generally broader than objectives, goals are still typically **quantifiable** or at least verifiable, meaning their attainment can be assessed.
Question 7: Rivastigmine & donepezil are drugs used predominantly in the management of ?
- A. Dissociation
- B. Dementia (Correct Answer)
- C. Delusions
- D. Depression
Explanation: ***Dementia*** - **Rivastigmine** and **donepezil** are **acetylcholinesterase inhibitors** that increase acetylcholine levels in the brain. - This mechanism is primarily used to improve **cognitive function** in patients with **Alzheimer's disease** and other forms of dementia. *Dissociation* - Dissociation involves a mental process causing a lack of connection between thoughts, memory, and identity, and is not typically treated with cholinesterase inhibitors. - Management often involves **psychotherapy** and sometimes anti-anxiety medications or antidepressants, if comorbid conditions are present. *Delusions* - Delusions are fixed, false beliefs often associated with psychotic disorders like **schizophrenia** or severe mood disorders. - Treatment primarily involves **antipsychotic medications**, not acetylcholinesterase inhibitors. *Depression* - Depression is a mood disorder characterized by persistent sadness and loss of interest. - It is typically treated with **antidepressants** (e.g., SSRIs, SNRIs), psychotherapy, or lifestyle changes, none of which include rivastigmine or donepezil.
Question 8: Regarding Alzheimer's disease which is/are not true :
- A. Initial loss of long term memory
- B. Step ladder pattern
- C. Delayed loss of short term memory
- D. All of the options (Correct Answer)
Explanation: ***Correct Option: All of the options*** - All three statements provided are **incorrect descriptions** of Alzheimer's disease. - In Alzheimer's disease, **short-term memory loss occurs early** (not delayed), **long-term memory is preserved initially** (not lost first), and progression is **gradual and continuous** (not step-ladder pattern). - Since all the statements are "not true" about Alzheimer's, "All of the options" is the correct answer to this negatively worded question. *Incorrect Statement: Initial loss of long term memory* - This is **NOT TRUE** for Alzheimer's disease. - Alzheimer's is characterized by **early impairment of short-term memory** (new memory formation). - Patients struggle to recall recent events or learn new information, while **long-term memories from the past** are preserved until later stages. - Remote memories (childhood, early adulthood) remain relatively intact in early-to-moderate disease. *Incorrect Statement: Step ladder pattern* - This is **NOT TRUE** for Alzheimer's disease. - Alzheimer's progression is typically **gradual, insidious, and continuous** with steady cognitive decline. - A **step-ladder (stepwise) pattern** with sudden declines followed by plateaus is characteristic of **vascular dementia**, resulting from multiple cerebrovascular events. - The stepwise deterioration reflects discrete vascular insults, not the neurodegenerative process of Alzheimer's. *Incorrect Statement: Delayed loss of short term memory* - This is **NOT TRUE** for Alzheimer's disease. - **Short-term memory loss** is one of the **earliest and most prominent symptoms** of Alzheimer's disease, not delayed. - Classic early presentations include difficulty recalling recently learned information, forgetting appointments, repeating questions, and misplacing items. - The hippocampus, critical for forming new memories, is affected early in the disease process.
Question 9: Which of the following antidepressants can be safely used in elderly depression?
- A. Trazodone
- B. Mianserin (Correct Answer)
- C. Fluoxetine
- D. Phenelzine
Explanation: In geriatric psychiatry, the choice of antidepressant is dictated by the side-effect profile, specifically the risk of anticholinergic effects, sedation, and cardiovascular complications. **Why Mianserin is correct:** Mianserin is a tetracyclic antidepressant (TeCA) that is frequently preferred in the elderly because it lacks significant **anticholinergic side effects** (which cause confusion, urinary retention, and glaucoma) and has minimal **cardiotoxicity**. It is particularly useful in elderly patients with insomnia or agitation due to its sedative properties, but it does not typically cause the severe orthostatic hypotension seen with older TCAs. **Analysis of Incorrect Options:** * **Fluoxetine (Option C):** While SSRIs are first-line for the elderly, Fluoxetine has a very **long half-life** (and active metabolites) which can lead to accumulation and prolonged side effects (like hyponatremia/SIADH or agitation) in patients with age-related renal or hepatic decline. Sertraline is generally preferred over Fluoxetine in this age group. * **Trazodone (Option A):** Though used for sleep, it is notorious for causing significant **orthostatic hypotension** in the elderly, increasing the risk of falls and hip fractures. * **Phenelzine (Option D):** As a non-selective MAOI, it requires strict dietary restrictions and carries a high risk of **hypertensive crisis** and drug-drug interactions, making it unsafe for the polypharmacy often seen in geriatric patients. **NEET-PG High-Yield Pearls:** * **Drug of Choice:** SSRIs (specifically **Sertraline** or **Escitalopram**) are generally the first-line treatment for elderly depression. * **Mianserin Risk:** Always monitor for **agranulocytosis** (rare but serious). * **Avoid:** Tertiary amines (Amitriptyline, Imipramine) due to high anticholinergic activity. * **Key Concern:** Always check for **hyponatremia** (SIADH) when starting an SSRI in an elderly patient.
Question 10: "Sundowning" is seen in which of the following conditions?
- A. Night blindness
- B. Parkinsonism
- C. Delirium (Correct Answer)
- D. Solar urticaria
Explanation: **Explanation:** **Sundowning** refers to a clinical phenomenon characterized by the emergence or worsening of neuropsychiatric symptoms—such as agitation, confusion, anxiety, and aggressiveness—specifically during the late afternoon or evening hours. **Why Delirium is the Correct Answer:** Sundowning is most commonly associated with **Delirium** and **Dementia** (particularly Alzheimer’s disease). It occurs due to a combination of factors: the loss of daylight (fading circadian cues), sensory deprivation in low light, and accumulated fatigue throughout the day. In patients with pre-existing cognitive impairment, the brain's ability to process environmental stimuli diminishes as light levels drop, leading to acute disorientation and behavioral disturbances. **Analysis of Incorrect Options:** * **A. Night blindness:** This is a physiological inability to see in low light (often due to Vitamin A deficiency) and does not involve the cognitive or behavioral agitation seen in sundowning. * **B. Parkinsonism:** While Parkinson’s patients may experience sleep disturbances or dementia-related confusion, sundowning is not a hallmark feature of the motor syndrome itself. * **D. Solar urticaria:** This is a physical dermatological condition (hives) triggered by exposure to ultraviolet radiation, the opposite of the "diminishing light" trigger of sundowning. **High-Yield Clinical Pearls for NEET-PG:** * **Management:** The first step in managing sundowning is optimizing the environment (e.g., keeping the room well-lit during the evening, reducing noise, and maintaining a strict routine). * **Differential:** Always rule out a "Medical Delirium" (UTI, electrolyte imbalance) if sundowning symptoms appear suddenly. * **Pharmacology:** If behavioral interventions fail, low-dose atypical antipsychotics (like Quetiapine) or Melatonin may be considered, though they are secondary to environmental modification.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free